Inventor · disambiguated record
Eric Valeur
Also filed as: VALEUR ERIC · VALEUR ERIC BRUNO
13 granted patents·8 pending applications·38 citations·filing 2009–2024
88Inventor score
Top patents by PatentIndex Score
21 records- 0188US10414726B2Therapeutic agentsCANCER RESEARCH TECH LTD·Filed 2017·Granted Sep 17, 2019·6 cites·19 claims
- 0287US9358222B2Therapeutic agentsCANCER REC TECH LTD·Filed 2013·Granted Jun 7, 2016·9 cites·12 claims
- 0383US8618158B2Therapeutic agentsGOLDING BERNARD THOMAS·Filed 2009·Granted Dec 31, 2013·10 cites·19 claims
- 0482US12115225B2GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereofASTRAZENECA AB·Filed 2021·Granted Oct 15, 2024·1 cites·12 claims
- 0576US8835634B2Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetesMERCK PATENT GMBH·Filed 2013·Granted Sep 16, 2014·3 cites·7 claims
- 0674US8415352B2Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetesBOTTON GERARD·Filed 2009·Granted Apr 9, 2013·2 cites·11 claims
- 0772US9452990B2Complement pathway modulators and uses thereofDECHANTSREITER MICHAEL·Filed 2013·Granted Sep 27, 2016·6 cites·15 claims
- 0872US2024293563A1Glp-1 receptor ligand moiety conjugated oligonucleotides and uses thereofASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0963US8178556B2Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetesBOTTON GERARD·Filed 2009·Granted May 15, 2012·0 cites·15 claims
- 1061US8486964B2Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitorsVALEUR ERIC·Filed 2009·Granted Jul 16, 2013·1 cites·18 claims
- 1155US2025122502A1Bifunctional Molecules and Methods of Using ThereofFLAGSHIP PIONEERING INC·Filed 2022·Application pending·0 cites
- 1254US9233937B2Method of stimulating insulin secretion and/or modulating INS-1 kinase with substituted pyrazinones and/or substituted tetrahydroquinoxalinonesMERCK PATENT GMBH·Filed 2014·Granted Jan 12, 2016·0 cites·15 claims
- 1353US8815859B2Substituted pyrazin-2-ones and substituted 5,6,7,8-tetrahydroquinoxalin-2-ones and methods of use thereofBOTTON GÉRARD·Filed 2009·Granted Aug 26, 2014·0 cites·11 claims
- 1453US8642617B2Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetesBOTTON GERARD·Filed 2012·Granted Feb 4, 2014·0 cites·18 claims
- 1553US8609689B2Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetesBOTTON GERARD·Filed 2012·Granted Dec 17, 2013·0 cites·19 claims
- 1652US2020268898A1Glp-1 receptor ligand moiety conjugated oligonucleotides and uses thereofASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 1752US2016355478A1Therapeutic agentsCANCER RES TECH LTD·Filed 2016·Application pending·0 cites
- 1852US2023158156A1Bifunctional molecules and methods of using thereofFLAGSHIP PIONEERING INC·Filed 2021·Application pending·0 cites
- 1951US2023167450A1Bifunctional molecules and methods of using thereofFLAGSHIP PIONEERING INC·Filed 2021·Application pending·0 cites
- 2046US2023332145A1Bifunctional molecules and methods of using thereofFLAGSHIP PIONEERING INC·Filed 2021·Application pending·0 cites
- 2141US2019134214A1GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses ThereofASTRAZENECA AB·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Valeur files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →